Abstract
We have cloned the rat fibroblast growth factor-2 (FGF-2) promoter region including 1058 base pairs (bp) of 5′-fianking DNA. Complete sequencing of this promoter region revealed a 74 bp domain between nucleotides -793 and -720 that was greater than 97% A/G-rich. A repeat of the sequence 5′-AGGGAGGG-3′ separated by 11 bp was located at the core of this domain. A 37 bp A/G-rich oligonucleotide containing these AGGG-repeat sequences was synthesised, and tested for function on a minimal herpes simplex virus thymidine kinase (TK) promoter, fused to the firefly luciferase gene (TKp.luc), in transiently transfected neonatal rat cardiac myocytes. Promoter activity was stimulated ∼3 fold in the presence of AGGG-repeat sequences. This effect was neither tissue or species-specific since TK promoter activity was increased ∼11 fold in both rat and human glial tumor cells. Four specific complexes (C1-4) were detected between neonatal rat heart nuclear proteins and the 37 bp A/G-rich oligonucleotide by gel mobility shift assay. Competition with excess unlabelled 37 bp A/G-rich oligonucleotide revealed that two complexes represented very high affinity/specificity interactions (C2 > C4) while C1 and C3 were of lower affinity. As a result, competition with up to a 25 fold molar excess of 37 bp A/G-rich oligonucleotide led to the loss of C2 and C4, and a corresponding and transient increase in the levels of C1 and C3, which themselves were reduced with more competitor oligonucleotide. The AGGG-repeat resembles the 5′-gGGGAGGG-3′ sequence previously implicated in the response of the atrial natriuretic factor promoter to the α-adrenergic agonist, phenylephrine. Although an additional 1.5 fold increase in TK promoter activity was detected in the presence of the 37 bp A/G-rich oligonucleotide with phenylephrine treatment of transfected myocytes, this effect was not statistically significant. Furthermore, there was no difference in the gel mobility shift (C1-4) pattern obtained with the 37 bp A/G-rich oligonucleotide and nuclear protein isolated from neonatal rat cardiac myocytes grown in the presence or absence of norepinephrine. These data suggest that the A/G rich sequences in the rat FGF-2 gene 5′-flanking DNA, including the AGGG-repeat, are able to confer stimulatory activity on a promoter in a tissue- and species-independent manner, but alone are not able to induce a significant phenylephrine response in neonatal rat cardiac myocytes. (Mol Cell Biochem 188: 169–176, 1998)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sugi Y, Sasse J, Lough J: Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2). Dev Biol 157: 28–37, 1993
Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T: Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA 92: 467–471, 1995
Clarke MS, Caldwell RW, Chiao H, Miyake K, McNeil PL: Contraction-induced cell wounding and release of basic fibroblast growth factor. Circ Res 76: 927–934, 1995
Kaye D, Pimentai D, Prasad S, Maki S, Berger HJ, McNeil PL, Smith TW, Kelly RA: Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 97: 281–291, 1996
Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Ningbeil C, Epstein SE: Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266 (Heart Circ Physiol 35): H158–H1595, 1994
Lazarous DF, Scheinowitz M, Shou M, Hodge E, Majanayagam MAS, Hunsberger S, Robinson Jr WG, Stiber JA, Correa R, Epstein SE, Unger EF: Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91: 145–153, 1995
Fox JC, Shanley JR: Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 271: 12578–12584, 1996
Padua RR, Sethi R, Dhalla NS, Kardami E: Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 143: 129–135, 1995
Padua RR, Sethi R, Davey-Forgie SE, Lui L, Dhalla N, Kardami E: Cardioprotection and basic fibroblast growth factor. In: N.S. Dhalla, P.K. Singal, R.E. Beamish (eds). Heart Hypertrophy and Failure. Kluwer Academic Publishers, Boston, 1996, pp 501–518.
Shibata F, Baird A, Florkiewicz RZ: Functional characterization of the human basic fibroblast growth factor promoter. Growth Factors 4: 277–287, 1991
Pasumarthi KBS, Jin Y, Cattini PA: Cloning of the rat fibroblast growth factor-2 promoter region and its response to mitogenic stimuli in glioma C6 cells. JNeurochem 68: 898–908, 1997
UebaT, NosakaT, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, OdaY, Kikuchi H, Hatanaka M: Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastma and hepatocellular carcinoma cells. Proc Natl Acad Sci USA 91: 9009–9013, 1994
Biesiada E, Razandi M, Levin ER: Egr-1 activates basic fibroblast growth factor transcription. J Biol Chem 271: 18576–18581, 1996
Ardati A, Nemer M A nuclear pathway for α1-adrenergic receptor signaling in cardiac cells. EMBO J 12: 5131–5139, 1993
Pasumarthi KBS, Kardami E, Cattini PA: High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology: Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res 78: 126–136, 1996
Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 11: 1475–1489, 1983
Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNAbinding proteins from limiting numbers of mammalian cells. Nucl Acids Res 19: 2499, 1991
Nordeen SK: Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6: 454–458, 1988
Smith PK, Krohn RI, Hermansen GT, Mallia AK, Gartner FH, Fugimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85, 1985
Baldwin AS: Analysis of sequence-specific DNA-binding proteins by the gel mobility shift assay. DNA Protein Eng Tech 2: 73–76, 1990
Lytras A, Cattini PA: Human chorionic somatomammotropin gene enhancer activity is dependent on the blockade of a repressor mechanism. Mol Endocrinol 8: 478–489, 1994
Boulikas T: Homeodomain protein binding sites, inverted repeats, and nuclear matrix attachment regions along the human ²-globin gene complex. J Cell Biochem 52: 23–36, 1993
Kardami E, Liu L, Padua RR, Fandrich RR, Pasumarthi SKB, Cattini PA: Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Ann NY Acad Sci 752: 353–369, 1995
Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocrine Rev 18: 26–45, 1997
Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292–15297, 1996
Sprenkle AB, Murray SF, Glembotski CC: Involvement of multiple cis-elements in basal and α-adrenergic agonist-inducible ANF transcription. Roles for serum response elements and an Sp-1-like element. Circ Res 77: 1060–1069, 1995
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Detillieux, K.A., Meyers, A.F.A., Meij, J.T.A., Cattini, P.A. (1998). An A/G-rich motif in the rat fibroblast growth factor-2 gene confers enhancer activity on a heterologous promoter in neonatal rat cardiac myocytes. In: Pierce, G.N., Izumi, T., Rupp, H., Grynberg, A. (eds) Molecular and Cellular Effects of Nutrition on Disease Processes. Developments in Molecular and Cellular Biochemistry, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5763-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5763-0_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7641-5
Online ISBN: 978-1-4615-5763-0
eBook Packages: Springer Book Archive